| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |